Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.

Flygt, Hjalmar (författare)

Uppsala universitet,Institutionen för medicinska vetenskaper,Department of Medical Science and Division of Hematology, Uppsala University Hospital, Uppsala, Sweden

Söderlund, Stina (författare)

Uppsala universitet,Institutionen för medicinska vetenskaper,Department of Medical Science and Division of Hematology, Uppsala University Hospital, Uppsala, Sweden

Richter, Johan (författare)

Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden

visa fler...

Saussele, Susanne (författare)

Medical Clinic, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany

Koskenvesa, Perttu (författare)

Department of Hematology, Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Stenke, Leif (författare)

Department of Hematology, Karolinska University Hospital and Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Mustjoki, Satu (författare)

Department of Hematology, Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland; ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland

Dimitrijevic, Andreja (författare)

Department of Hematology, Odense University Hospital, Odense, Denmark

Stentoft, Jesper (författare)

Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

Majeed, Waleed (författare)

Department of Hemato-Oncology, Stavanger University Hospital, Stavanger, Norway

Roy, Lydia (författare)

French CML group Fi-LMC, Centre Léon Bérard, Lyon, Hôpital Universitaire Henri Mondor, AP-HP, Service d'hématologie Clinique & Faculté de Santé, Université Paris Est Créteil, Créteil, France

Wolf, Dominik (författare)

Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University Innsbruck, Innsbruck, Austria; Medical Clinic 3, Universitätsklinikum, Bonn, Germany

Dreimane, Arta (författare)

Department of Hematology, Linköping University Hospital, Linköping, Sweden

Gjertsen, Bjørn Tore (författare)

Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway

Gedde-Dahl, Tobias (författare)

Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Ahlstrand, Erik, 1974- (författare)

Region Örebro län,Örebro universitet, Institutionen för medicinska vetenskaper,Department of Medicine

Markevärn, Berit (författare)

Department of Hematology, Umeå University Hospital, Umeå, Sweden

Hjorth-Hansen, Henrik (författare)

Department of Hematology, St. Olavs Hospital, Trondheim, Norway

Janssen, Jeroen (författare)

Department of Hematology, Radboud University medical center, Nijmegen, The Netherlands

Olsson-Strömberg, Ulla (författare)

Department of Medical Science and Division of Hematology, Uppsala University Hospital, Uppsala, Sweden

visa färre...

 (creator_code:org_t)

2024

2024

Engelska.

Ingår i: Leukemia. - : Springer. - 0887-6924 .- 1476-5551.

Relaterad länk:

https://doi.org/10.1...

visa fler...

https://urn.kb.se/re...

https://doi.org/10.1...

https://urn.kb.se/re...

http://kipublication...

visa färre...

• Tidskriftsartikel (refereegranskat)